UNLABELLED: More than 750 million people are at risk of infection with foodborne liver flukes. Opisthorchis viverrini is considered among the most important of these parasites, due to its strong association with cholangiocarcinoma (CCA). O. viverrini infection results in a chronic inflammatory challenge to the host, which can lead to advanced, pathogen-specific disease sequelae including obstructive jaundice, hepatomegaly, cholecystitis, as well as CCA. However, before disease sequelae are apparent, important inflammatory changes to the liver can be detected early during O. viverrini infection. In a case-control study involving 328 men and women with O. viverrini infection, we determined the presence of advanced periductal fibrosis in asymptomatic, O. viverrini-infected individuals and then measured cytokine responses to O. viverrini excretory/secretory products (ES). In the 200 participants with advanced periductal fibrosis (cases), levels of interleukin-6 (IL-6) to O. viverrini ES were 8 times higher than levels of the 128 O. viverrini-infected individuals without advanced periductal fibrosis (controls). Moreover, elevated IL-6 to parasite ES was associated with increased risk of advanced periductal fibrosis by 63% in a model adjusted for sex and age. The risk of advanced periductal fibrosis was also found to increase with higher levels of IL-6: individuals in the third quartile of IL-6-ES production had a 127% higher risk of developing advanced periductal fibrosis than individuals in the first quartile of IL-6 production. O. viverrini-infected individuals with advanced periductal fibrosis showed other hepatobiliary abnormalities, including reduced gallbladder contractility and the presence of gallbladder sludge. CONCLUSION: These data strongly implicate a role for parasite-specific IL-6 in the pathogenesis of advanced periductal fibrosis in opisthorchiasis, with possible links to other hepatobiliary abnormalities, including CCA.
UNLABELLED: More than 750 million people are at risk of infection with foodborne liver flukes. Opisthorchis viverrini is considered among the most important of these parasites, due to its strong association with cholangiocarcinoma (CCA). O. viverriniinfection results in a chronic inflammatory challenge to the host, which can lead to advanced, pathogen-specific disease sequelae including obstructive jaundice, hepatomegaly, cholecystitis, as well as CCA. However, before disease sequelae are apparent, important inflammatory changes to the liver can be detected early during O. viverriniinfection. In a case-control study involving 328 men and women with O. viverriniinfection, we determined the presence of advanced periductal fibrosis in asymptomatic, O. viverrini-infected individuals and then measured cytokine responses to O. viverrini excretory/secretory products (ES). In the 200 participants with advanced periductal fibrosis (cases), levels of interleukin-6 (IL-6) to O. viverriniES were 8 times higher than levels of the 128 O. viverrini-infected individuals without advanced periductal fibrosis (controls). Moreover, elevated IL-6 to parasite ES was associated with increased risk of advanced periductal fibrosis by 63% in a model adjusted for sex and age. The risk of advanced periductal fibrosis was also found to increase with higher levels of IL-6: individuals in the third quartile of IL-6-ES production had a 127% higher risk of developing advanced periductal fibrosis than individuals in the first quartile of IL-6 production. O. viverrini-infected individuals with advanced periductal fibrosis showed other hepatobiliary abnormalities, including reduced gallbladder contractility and the presence of gallbladder sludge. CONCLUSION: These data strongly implicate a role for parasite-specific IL-6 in the pathogenesis of advanced periductal fibrosis in opisthorchiasis, with possible links to other hepatobiliary abnormalities, including CCA.
Authors: E Mairiang; D B Elkins; P Mairiang; J Chaiyakum; N Chamadol; V Loapaiboon; S Posri; P Sithithaworn; M Haswell-Elkins Journal: J Gastroenterol Hepatol Date: 1992 Jan-Feb Impact factor: 4.029
Authors: D B Elkins; E Mairiang; P Sithithaworn; P Mairiang; J Chaiyakum; N Chamadol; V Loapaiboon; M R Haswell-Elkins Journal: Am J Trop Med Hyg Date: 1996-09 Impact factor: 2.345
Authors: E Mairiang; M R Haswell-Elkins; P Mairiang; P Sithithaworn; D B Elkins Journal: Trans R Soc Trop Med Hyg Date: 1993 Mar-Apr Impact factor: 2.184
Authors: T H Mauad; C M van Nieuwkerk; K P Dingemans; J J Smit; A H Schinkel; R G Notenboom; M A van den Bergh Weerman; R P Verkruisen; A K Groen; R P Oude Elferink Journal: Am J Pathol Date: 1994-11 Impact factor: 4.307
Authors: S Kakumu; T Shinagawa; T Ishikawa; K Yoshioka; T Wakita; Y Ito; M Takayanagi; N Ida Journal: Am J Gastroenterol Date: 1991-12 Impact factor: 10.864
Authors: Michael J Smout; Banchob Sripa; Thewarach Laha; Jason Mulvenna; Robin B Gasser; Neil D Young; Jeffrey M Bethony; Paul J Brindley; Alex Loukas Journal: Mol Biosyst Date: 2011-02-11
Authors: Neil D Young; Bronwyn E Campbell; Ross S Hall; Aaron R Jex; Cinzia Cantacessi; Thewarach Laha; Woon-Mok Sohn; Banchob Sripa; Alex Loukas; Paul J Brindley; Robin B Gasser Journal: PLoS Negl Trop Dis Date: 2010-06-22